HOME >> MEDICINE >> NEWS
Alcohol may lower risk of non-Hodgkin's lymphoma

People who drink alcohol may have a lower risk of developing non-Hodgkin's lymphoma (NHL)--a type of cancer that affects the lymphatic system, suggests a study published online today (Tuesday June 7, 2005) by THE LANCET ONCOLOGY.

Scientists know that alcohol increases the risk of several cancers, including those of the oral cavity, oesophagus, and liver. But previous studies looking at the relation between alcohol consumption and NHL have been inconsistent. Over the past few decades the incidence of NHL has risen worldwide, and in developed countries NHL is the sixth most common cancer in men and eighth most common in women.

Lindsay Morton (National Institutes of Health, Maryland, USA) and colleagues did a pooled analysis combining original data from nine studies from the USA, UK, Sweden, and Italy, involving 15,000 individuals (6,500 people with NHL and 8,600 healthy individuals). The researchers found that the risk of NHL was about 27% lower for current drinkers than for non-drinkers, but the risk did not change with increasing alcohol consumption. The risk also did not change with the age individuals began drinking, total lifetime consumption, or beverage type. The risk did vary by NHL subtype, with the lowest risk recorded for Burkitt's lymphoma. Compared with non-drinkers, ever drinkers had about half the risk of developing Burkitt's lymphoma. Age, sex, family history of NHL, or history of cigarette smoking did not modify the effect of alcohol consumption on risk of NHL or NHL subtypes.

Dr Morton and colleagues state: "Our pooled analysis of alcohol consumption and NHL risk suggests that people who drink alcoholic beverages have a lower risk of NHL than those who do not. This relation does not seem to depend on the type of alcoholic beverage consumed, but might vary by NHL subtype. Future research to confirm these findings by use of prospective data, and to determine the likely biological mechanism, is warranted."


'"/>

Contact: Joe Santangelo
j.santangelo@elsevier.com
1-212-633-3810
Lancet
6-Jun-2005


Page: 1

Related medicine news :

1. Alcohol interventions that teach practical skills work best with high-risk university students
2. Numbers, sequences pose problems for Fetal Alcohol Syndrome children
3. Alcohol and high-risk sexual behaviors in Botswana
4. Alcoholics Anonymous membership may decrease alcohol-related homicides
5. Alcoholism-treatment medication acamprosate may help abstinent alcoholics sleep better
6. Alcohol increases sleep intensity in young women
7. Alcohol consumption habits may threaten GI health
8. Alcoholics with a borderline personality disorder are at greatest risk for suicidal behavior
9. Alcohol-branded merchandise associated with early teen drinking
10. Alcohol-deterrent drugs help patients achieve high rates of long-term abstinence
11. Alcohol advertising may contribute to increased drinking among young people

Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Alcohol may lower risk non Hodgkin lymphoma

(Date:4/23/2014)... "simple and accessible detection methods that can rapidly ... of a single cell inside that population has ... Chang Lu. , In the Royal Society of ... announced that he and his coworkers have developed ... of a protein ( Chem. Sci. , 2014, ...
(Date:4/23/2014)... are often displayed in the popular Swedish children,s ... of high-sugar foods. A new study from the ... in children,s TV programmes as well as the ... and weight status. , Steingerdur Olafsdottir,s doctoral thesis ... popular Swedish children,s TV show Bolibompa. Healthy foods ...
(Date:4/23/2014)... led by a researcher from the Cancer Science Institute ... Singapore has identified the cancer specific stem cell which ... of developing new drugs for the treatment of this ... group, led by Dr Chan Shing Leng, Research Assistant ... that a cancer-specific variant of a cell surface protein, ...
(Date:4/23/2014)... in the journal Oncotarget , explored tumour ... or their own DNA signatures within the same ... design effective, targeted treatment strategies. , Firstly they ... and either the KRAS or BRAF mutation. Secondly, ... EGFR gene mutation have that specific mutation present ...
(Date:4/23/2014)... Alzheimer,s disease has been a rapidly evolving pursuit ... latest crook in the research road, scientists have ... proteins associated with the disease. The report, which ... , could have important implications for developing novel ... colleagues explain that for years, research has suggested ...
Breaking Medicine News(10 mins):Health News:Following a protein's travel inside cells is key to improving patient monitoring, drug development 2Health News:High-calorie and low-nutrient foods in kids' TV 2Health News:Scientists identify cancer specific cell for potential treatment of gastric cancer 2Health News:Scientists identify cancer specific cell for potential treatment of gastric cancer 3Health News:Non-uniform genetic mutations identified in lung cancers could lead to targeted treatment 2
(Date:1/15/2014)... , Jan. 15, 2014 Reportlinker.com announces ... available in its catalogue: ... Forecast and Market Analysis to 2022 ... Atopic Dermatitis - India Drug Forecast and ...
(Date:1/15/2014)... , Jan. 15, 2014  Zafgen, Inc., a ... needs of severely obese patients, today announced initial ... a selective inhibitor of methionine aminopeptidase 2 (MetAP2), ... form of genetic obesity.  These results showed improvements ...
(Date:1/14/2014)... InformEx, North America,s leading business partnering ... the 30 th edition of its annual conference at ... January 21-24. (Logo: http://photos.prnewswire.com/prnh/20131028/NY05330LOGO-a ) ... and specialty chemical companies will take part in the conference, ...
Breaking Medicine Technology:PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 2PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 3PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 4PharmaPoint: Atopic Dermatitis - India Drug Forecast and Market Analysis to 2022 5Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 2Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 3Zafgen Announces Initial Results from Phase 2a Study of Beloranib in Patients with Prader-Willi Syndrome 4Media Advisory: InformEx 2014 Events & Speaker Lineup for 30th Edition Conference in Miami Beach 2
Cached News: